Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse T Jacob

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Infection Control and Hospital Epidemiology|February 14, 2022
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) StudyJessica R Howard-Anderson, Carly Adams, William C Dube, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2022
Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple HospitalsClare Rock, Oluchi Abosi, Susan Bleasdale, et al.
Mbio|March 21, 2022
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial ResistanceAlina Iovleva, Mustapha M Mustapha, Marissa P Griffith, et al.
Open Forum Infectious Diseases|December 22, 2023
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020Nadezhda Duffy, Rongxia Li, Christopher A Czaja, et al.
Infection Control and Hospital Epidemiology|January 28, 2022
Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemiaGregory M Schrank, Anna Sick-Samuels, Susan C Bleasdale, et al.
JAMA Network Open|March 10, 2021
Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care PersonnelJesse T Jacob, Julia M Baker, Scott K Fridkin, et al.
Microbiology Spectrum|April 17, 2023
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. SitesJoseph D Lutgring, Julian E Grass, David Lonsway, et al.
The Journal of Infectious Diseases|November 24, 2023
Associations Between HIV and Severe Mpox in an Atlanta CohortBruce Aldred, Jane Y Scott, Amalia Aldredge, et al.
Emerging Infectious Diseases|March 20, 2018
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015Sandra N Bulens, Sarah H Yi, Maroya S Walters, et al.
JAMA Internal Medicine|January 8, 2024
Early Tecovirimat Treatment for Mpox Disease Among People With HIVBruce Aldred, Robert H Lyles, Jane Y Scott, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Infection Control and Hospital Epidemiology|February 14, 2022
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) StudyJessica R Howard-Anderson, Carly Adams, William C Dube, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2022
Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple HospitalsClare Rock, Oluchi Abosi, Susan Bleasdale, et al.
Mbio|March 21, 2022
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial ResistanceAlina Iovleva, Mustapha M Mustapha, Marissa P Griffith, et al.
Open Forum Infectious Diseases|December 22, 2023
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020Nadezhda Duffy, Rongxia Li, Christopher A Czaja, et al.
Infection Control and Hospital Epidemiology|January 28, 2022
Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemiaGregory M Schrank, Anna Sick-Samuels, Susan C Bleasdale, et al.
JAMA Network Open|March 10, 2021
Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care PersonnelJesse T Jacob, Julia M Baker, Scott K Fridkin, et al.
Microbiology Spectrum|April 17, 2023
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. SitesJoseph D Lutgring, Julian E Grass, David Lonsway, et al.
The Journal of Infectious Diseases|November 24, 2023
Associations Between HIV and Severe Mpox in an Atlanta CohortBruce Aldred, Jane Y Scott, Amalia Aldredge, et al.
Emerging Infectious Diseases|March 20, 2018
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015Sandra N Bulens, Sarah H Yi, Maroya S Walters, et al.
JAMA Internal Medicine|January 8, 2024
Early Tecovirimat Treatment for Mpox Disease Among People With HIVBruce Aldred, Robert H Lyles, Jane Y Scott, et al.
Pageof 15